HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New York Cosmetic Ingredient Bill Still In Committee With Clock Running Out

Executive Summary

New York continues chasing California in its efforts to increase regulation of the cosmetic products sector.

You may also be interested in...



Unilever To Fuel Skin Care, E-Commerce Engines With Paula’s Choice Acquisition

Paula’s Choice ticks skin-care and e-commerce boxes at a time of increased wellness and home shopping demand. The balance it strikes between acknowledging consumer ingredient preferences and upholding scientific method may also be part of the brand's appeal.

Cosmetics Industry Should ‘Double Down’ On Self-Regulation While Awaiting Reform Legislation

Covington & Burling attorney Peter Barton Hutt brings historical perspective to the matter of cosmetics reform legislation in US Congress, which stalled out in 2020 after COVID hit the states. He advises companies to continue working to meet and exceed existing regulatory requirements "so that people can’t say that voluntary self-regulation doesn’t work."

California DTSC Eyeing Residual MMA In Nail Products, While NGOs Call For Wider Look At Acrylates

Coty, Inc. says methyl methacrylate detected in salon air is “usually the result of illicit use of currently illegal MMA liquid monomer,” but California’s DTSC is not so sure. The California Healthy Nail Salon Collaborative says acrylates used to replace MMA, or otherwise found in nail products, pose concerns of their own that warrant investigation under the state's Safer Consumer Products regulation.

Related Content

Topics

UsernamePublicRestriction

Register

RS151403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel